LABORATOIRES RIVADIS SAS : revenue, balance sheet and financial ratios

LABORATOIRES RIVADIS SAS is a French company founded 37 years ago, specialized in the sector Fabrication de parfums et de produits pour la toilette. Based in LOUZY (79100), this company of category ETI shows in 2025 a revenue of 46.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRES RIVADIS SAS (SIREN 347956336)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 46 644 101 € 40 260 927 € 36 715 558 € 34 173 819 € 34 394 067 € 30 333 096 € 33 142 267 € N/C 43 287 158 € 41 601 501 €
Net income -853 110 € -387 901 € -658 859 € -1 916 219 € -594 277 € 924 499 € 457 272 € 38 948 € 807 590 € 1 080 187 €
EBITDA 1 443 970 € 870 699 € 278 985 € -1 921 397 € -299 779 € 2 829 724 € 1 843 652 € -35 609 482 € 2 054 422 € 4 113 032 €
Net margin -1.8% -1.0% -1.8% -5.6% -1.7% 3.0% 1.4% N/C 1.9% 2.6%

Revenue and income statement

In 2025, LABORATOIRES RIVADIS SAS achieves revenue of 46.6 M€. Revenue is growing positively over 10 years (CAGR: +1.3%). Vs 2024, growth of +16% (40.3 M€ -> 46.6 M€). After deducting consumption (26.5 M€), gross margin stands at 20.2 M€, i.e. a rate of 43%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.4 M€, representing 3.1% of revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -853 k€ (-1.8% of revenue), which will impact equity.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

46 644 101 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

20 163 803 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 443 970 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-803 349 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-853 110 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

3.1%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 364%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 14.6 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

364.451%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

11.726%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

1.107%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

14.566

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

14.4%

Solvency indicators evolution
LABORATOIRES RIVADIS SAS

Sector positioning

Debt ratio
364.45 2025
2023
2024
2025
Q1: 2.62
Med: 22.48
Q3: 99.79
Watch +6 pts over 3 years

In 2025, the debt ratio of LABORATOIRES RIVADIS SAS (364.45) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
11.73% 2025
2023
2024
2025
Q1: 21.76%
Med: 42.99%
Q3: 56.54%
Watch -11 pts over 3 years

In 2025, the financial autonomy of LABORATOIRES RIVADIS SAS (11.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
14.57 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 2.04 years
Q3: 8.13 years
Watch +22 pts over 3 years

In 2025, the repayment capacity of LABORATOIRES RIVADIS SAS (14.57) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 175.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 12.7x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

175.26

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

12.73

Liquidity indicators evolution
LABORATOIRES RIVADIS SAS

Sector positioning

Liquidity ratio
175.26 2025
2023
2024
2025
Q1: 129.36
Med: 216.47
Q3: 313.72
Average -10 pts over 3 years

In 2025, the liquidity ratio of LABORATOIRES RIVADIS SAS (175.26) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
12.73x 2025
2023
2024
2025
Q1: 0.01x
Med: 2.42x
Q3: 10.47x
Excellent

In 2025, the interest coverage of LABORATOIRES RIVADIS SAS (12.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 49 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 55 days. Favorable situation: supplier credit is longer than customer credit by 6 days. Inventory turnover is 39 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 91 days of revenue, i.e. 11.8 M€ to permanently finance. Over 2016-2025, WCR increased by +68%, requiring additional financing.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

11 758 045 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

49 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

55 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

39 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

91 j

WCR and payment terms evolution
LABORATOIRES RIVADIS SAS

Positioning of LABORATOIRES RIVADIS SAS in its sector

Comparison with sector Fabrication de parfums et de produits pour la toilette

Valuation estimate

Based on 74 transactions of similar company sales (all years), the value of LABORATOIRES RIVADIS SAS is estimated at 2 485 418 € (range 1 424 729€ - 5 672 119€). With an EBITDA of 1 443 970€, the sector multiple of 0.6x is applied. The price/revenue ratio is 0.11x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
74 tx
1424k€ 2485k€ 5672k€
2 485 418 € Range: 1 424 729€ - 5 672 119€
Section all-time Aggregated at NAF section level

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 443 970 € × 0.6x
Estimation 902 518 €
273 422€ - 2 081 236€
Revenue Multiple 30%
46 644 101 € × 0.11x
Estimation 5 123 586 €
3 343 576€ - 11 656 926€
How is this estimate calculated?

This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de parfums et de produits pour la toilette)

Compare LABORATOIRES RIVADIS SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de parfums et de produits pour la toilette

Frequently asked questions about LABORATOIRES RIVADIS SAS

What is the revenue of LABORATOIRES RIVADIS SAS ?

The revenue of LABORATOIRES RIVADIS SAS in 2025 is 46.6 M€.

Is LABORATOIRES RIVADIS SAS profitable?

LABORATOIRES RIVADIS SAS recorded a net loss in 2025.

Where is the headquarters of LABORATOIRES RIVADIS SAS ?

The headquarters of LABORATOIRES RIVADIS SAS is located in LOUZY (79100), in the department Deux-Sevres.

Where to find the tax return of LABORATOIRES RIVADIS SAS ?

The tax return of LABORATOIRES RIVADIS SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRES RIVADIS SAS operate?

LABORATOIRES RIVADIS SAS operates in the sector Fabrication de parfums et de produits pour la toilette (NAF code 20.42Z). See the 'Sector positioning' section above to compare the company with its competitors.